Designed to deter repeat use, auto disable syringes offer a significant advancement in the prevention of infection. These safety syringes prohibit their reuse by creating a mechanical barrier after the first use, either by blocking the barrel or by disrupting the plunger. A more advanced version of these syringes also provides needle stick prevention. This involves a sheath or hood component that shields the needle following its first usage, or a system whereby the needle retracts into the syringe’s barrel, either manually or spring-loaded, after a single application.
The sustained growth experienced by the auto disable syringes market can widely be attributed to several factors. The competitive landscape has marked the major players in the sector, which include corporations such as NIPRO Medical Corporation, Becton, Dickinson and Company, Boston Scientific Corporation, Baxter Healthcare Corporation, Medtronic plc., Smiths Medical, B. Braun Melsungen AG, Retractable Technologies, Inc., and Terumo Medical Corporation, alongside JMI Syringes & Medical Devices Limited.
One of the substantial market strategies that have proven effective to stimulate high-volume sales and premium pricing structure is the collaboration between these players and healthcare organizations. This strategic partnership with large hospitals and industry players stands to generate more dividends due to facilitating faster adoption and minimized cost.
For a more comprehensive understanding of the global auto disable syringes market, the industry analysts have provided qualitative and quantitative assessments, inputs from industry experts, and first-hand information. They have considered the parent market trends, macro-economic indicators, and governing factors, as well as the market attractiveness according to the segments.
Segmentation analysis and the subsequent impact of various market factors on different segments and geographical locations offer in-depth insights into the auto disable syringes market. This analysis relies on the mechanism, clinical indications, end-users, and region, all of which facilitate a more precise evaluation of the global auto disable syringes market.
Source: https://www.digitaljournal.com/pr/news/xherald/auto-disable-syringes-market-pioneering-safe-injections-and-combating-healthcare-associated-infections